Release Date: 18/02/20 08:19 Summary: Continued spectacular intersections support Deflector growth Price Sensitive: Yes Download Document 1.44MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%